⚠ Evidence warning: Clinical trials or other evidence do not support the claim that high cruciferous vegetable intake reduces breast cancer deaths in the first three years after diagnosis. This page keeps it as a report of what people, websites or other media say.

Kale Glucosinolates, Sulforaphane, and Cancer Chemoprevention

Glucosinolates and Cancer — scientific infographic poster

Kale, like every member of the Brassica genus, contains sulfur-rich glucosinolate compounds stored in cell vacuoles separate from the enzyme myrosinase. When the plant tissue is damaged by chewing, chopping, or insect feeding, the two compartments fuse and myrosinase hydrolyzes glucosinolates into a cascade of bioactive metabolites — isothiocyanates (the most-studied being sulforaphane from glucoraphanin), indoles (indole-3-carbinol from glucobrassicin, which further condenses to diindolylmethane), and minor nitriles. These metabolites induce the master cellular antioxidant transcription factor NRF2 (nuclear factor erythroid 2-related factor 2), which transcribes the Phase II detoxification enzymes (glutathione S-transferases, NAD(P)H quinone dehydrogenase 1 (NQO1; NAD(P)H is the reduced form of nicotinamide adenine dinucleotide phosphate), heme oxygenase-1) that conjugate and excrete carcinogens before they can damage DNA. The same metabolites modulate estrogen metabolism toward the protective 2-hydroxyestrone pathway and away from the proliferative 16-alpha-hydroxyestrone pathway. The epidemiologic translation has been consistent across breast, prostate, colorectal, lung, and bladder cancer cohorts — high cruciferous-vegetable intake is associated with 15-30% reductions in incidence, with the largest effects in individuals with GSTM1-null or GSTT1-null detoxification-gene polymorphisms. This deep-dive walks through the chemistry, the mechanism, the epidemiology, the pivotal Johns Hopkins broccoli-sprout work, and the practical question of how to prepare kale to maximize the bioactive yield.


Table of Contents

  1. Glucosinolate Chemistry in Kale
  2. The Myrosinase Activation Reaction
  3. Sulforaphane and the NRF2 Pathway
  4. Indole-3-Carbinol, DIM, and Estrogen Metabolism
  5. Breast Cancer Epidemiology
  6. Prostate and Colorectal Cancer
  7. Lung and Bladder Cancer
  8. GSTM1 / GSTT1 Polymorphisms and Personal Variability
  9. Broccoli Sprouts vs Mature Kale: Concentration vs Practicality
  10. Preparation for Maximum Bioactive Yield
  11. Cautions and Drug Interactions
  12. Key Research Papers
  13. Connections
  14. Featured Videos

Glucosinolate Chemistry in Kale

Glucosinolates are a family of secondary metabolites with a common chemical scaffold — a beta-thioglucose moiety, a sulfonated oxime group, and a variable side chain derived from a precursor amino acid. The plant uses them as a chemical defense system against herbivores and microbial pathogens. Approximately 130 distinct glucosinolates have been identified across the order Brassicales, with most plant species expressing a characteristic subset.

Kale (Brassica oleracea var. sabellica) typically contains a profile dominated by:

Total glucosinolate content of fresh kale typically falls in the range of 50-150 mg per 100 g fresh weight, with significant variation by cultivar, growing conditions, season, and post-harvest handling. Lacinato (dinosaur) kale tends toward the higher end; baby kale and curly kale toward the middle.

Back to Table of Contents

The Myrosinase Activation Reaction

The chemistry that makes brassicas pharmacologically interesting is the spatial separation of glucosinolates from the enzyme that activates them. In intact plant tissue, glucosinolates are stored in S-cells (specialized cells in the leaf vasculature), while the activating enzyme myrosinase (thioglucoside glucohydrolase, EC 3.2.1.147) is stored in adjacent myrosin cells. The two are physically separated until the plant tissue is damaged — by chewing, chopping, insect feeding, freezing, or crushing — at which point the cell walls rupture and myrosinase contacts its glucosinolate substrate.

The hydrolysis reaction is rapid (seconds to minutes) and produces a glucose moiety plus an unstable thiohydroximate-O-sulfonate intermediate. The intermediate undergoes spontaneous rearrangement to produce one of several products depending on the glucosinolate side chain, the pH, the presence of epithiospecifier protein (ESP), and the iron content of the cell:

Isothiocyanate yield is highest when the glucosinolates come in contact with active myrosinase under neutral-pH conditions. Two factors deactivate myrosinase: cooking heat (myrosinase is denatured at temperatures above ~70°C / 158°F, depending on duration) and stomach acid (the gastric pH of 1.5-2 destroys ingested myrosinase before it can act). The cooking question therefore turns on how much myrosinase activity each cooking method leaves — covered in the preparation section below and on the cooking page.

The good news: even when food-source myrosinase is fully destroyed by cooking, intact glucosinolates can be hydrolyzed by myrosinase-producing gut bacteria (notably Bifidobacterium and certain Lactobacillus species) in the colon. The conversion efficiency is much lower than with plant myrosinase (10-20% vs 60-80%), and inter-individual variability is high, but this colonic salvage pathway means cooked brassicas still deliver some isothiocyanate.

Back to Table of Contents

Sulforaphane and the NRF2 Pathway

Sulforaphane (4-methylsulfinylbutyl isothiocyanate) is the most extensively studied dietary chemopreventive agent. Its principal mechanism is induction of NRF2 (nuclear factor erythroid 2-related factor 2), the master transcription factor for the cellular antioxidant and Phase II detoxification response.

NRF2 is normally held in the cytoplasm bound to its inhibitor KEAP1 (Kelch-like ECH-associated protein 1), which targets NRF2 for ubiquitination and proteasomal degradation. KEAP1 contains reactive cysteine residues that act as oxidative-stress sensors. When sulforaphane (or other electrophilic compounds, or reactive oxygen species directly) modifies these cysteines, the KEAP1-NRF2 complex dissociates. Liberated NRF2 translocates to the nucleus, binds antioxidant response elements (AREs) in the promoter regions of cytoprotective genes, and induces transcription of:

The net effect is a coordinated upregulation of carcinogen detoxification and oxidative-stress defense, sustained for 2-3 days after a single dose of sulforaphane. Regular consumption of kale or other brassicas maintains a tonic activation of this protective response.

The Johns Hopkins group (Paul Talalay and colleagues) pioneered the broccoli-sprout work that established the NRF2 mechanism. The seminal 1992 paper by Zhang, Talalay and colleagues in PNAS isolated sulforaphane from mature broccoli as a major and very potent Phase II enzyme inducer, measured in cultured mouse liver-cancer (hepatoma) cells. The sprout finding came in 1997, when Fahey, Zhang and Talalay reported that three-day-old broccoli sprouts contain 10-100 times the glucoraphanin of the corresponding mature plants. Subsequent clinical trials in China and elsewhere have shown measurable urinary excretion of aflatoxin-glutathione conjugates and benzene-mercapturic acid metabolites after broccoli-sprout beverage consumption in environmentally exposed populations.

Back to Table of Contents

Indole-3-Carbinol, DIM, and Estrogen Metabolism

The second major chemopreventive pathway involves indole-3-carbinol (I3C), the hydrolysis product of glucobrassicin. I3C itself is unstable in stomach acid and rapidly condenses to diindolylmethane (DIM) and several minor oligomers. DIM is the dominant bioactive species reaching the systemic circulation and tissues.

DIM modulates the metabolism of estrogens through cytochrome P450 enzyme induction, shifting the balance between the two major estrogen 2-position and 16-alpha-position hydroxylation pathways:

The ratio of 2-OHE1 to 16-alpha-OHE1 (the "2/16 ratio") is a research-grade biomarker of estrogen metabolism. DIM supplementation in clinical trials has been shown to increase the 2/16 ratio, theoretically reducing the proliferative estrogen load on hormone-responsive tissues. The clinical translation to breast cancer prevention outcomes is plausible but not yet definitively established — the 2/16 ratio is a surrogate marker, not a cancer endpoint.

The practical implication: regular cruciferous-vegetable intake (kale, broccoli, cabbage, brussels sprouts) supports a more favorable estrogen-metabolite profile in pre-menopausal and post-menopausal women, which is one of several proposed mechanisms behind the consistent epidemiologic association between cruciferous intake and reduced breast cancer risk. For more on hormone-balancing strategies, see our Endocrinology category.

Back to Table of Contents

Breast Cancer Epidemiology

The cruciferous-vegetable-and-breast-cancer association has been studied in dozens of prospective cohorts. The 2013 meta-analysis by Liu and Lv pooled 13 studies (11 case-control and 2 cohort studies) and found a 15% lower breast cancer risk comparing the highest with the lowest cruciferous-vegetable intake (relative risk 0.85); because so few studies were available, the authors called for more prospective studies. Asian populations (Shanghai Women's Health Study, Singapore Chinese Health Study) consistently show stronger inverse associations than Western populations, possibly due to higher baseline intake levels (Asian cohorts averaging 100+ g/day vs Western cohorts averaging 20-30 g/day) and earlier exposure (cruciferous greens consumed regularly from childhood).

A 2024 umbrella review that gathered 22 meta-analyses (covering 175 cancer studies) found that the evidence for lung, stomach, prostate, breast, endometrial and ovarian cancer and kidney cell cancer (renal cell carcinoma) points to a possible link between cruciferous intake and cancer risk; its authors wrote that the quality of the evidence still needs improving before that link can be shown.

Whether eating cruciferous vegetables after a diagnosis changes the outcome is less clear. The 2013 After Breast Cancer Pooling Project combined four cohorts of 11,390 breast cancer survivors in the United States and Shanghai, followed for a median of 9 years (1,725 deaths and 1,421 recurrences): cruciferous intake measured about two years after diagnosis was not linked to recurrence or death, including in subgroups by estrogen-receptor status, stage or tamoxifen use. A reduction in breast cancer mortality has been reported among women in the highest cruciferous-intake quintile during the first three years after diagnosis, suggesting the effect operates on tumor progression and not only initiation. The Long Island Breast Cancer Study Project found inverse associations with both estrogen-receptor-positive and triple-negative breast cancer subtypes, with the effect on triple-negative disease being numerically larger.

The mechanism is mechanistically plausible across multiple pathways — sulforaphane induction of Phase II carcinogen detoxification, DIM modulation of estrogen metabolism, sulforaphane and DIM inhibition of histone deacetylases (epigenetic modulation), and sulforaphane induction of apoptosis in transformed cells. The convergent mechanistic evidence supports the epidemiologic association.

Important caveat: the cohort studies use questionnaire-based intake assessment with substantial measurement error, and the effect sizes are modest (15-25% relative risk reduction). Cruciferous vegetables are not a substitute for screening, primary prevention, or treatment of breast cancer. They are a meaningful but small contributor to lifetime risk modification.

Back to Table of Contents

Prostate and Colorectal Cancer

Prostate cancer. A 2000 Seattle-area case-control study (Cohen, Kristal and Stanford; 628 men with prostate cancer and 602 controls, all under 65) found 35% lower odds of prostate cancer in men eating 28 or more servings of vegetables a week compared with fewer than 14 (odds ratio 0.65); for cruciferous vegetables, three or more servings a week compared with less than one gave an odds ratio of 0.59, after allowing for total vegetable intake. A 2023 meta-analysis of 7 case-control and 9 cohort studies (70,201 prostate cancer cases among 1,264,437 people) found a 13% lower risk at the highest compared with the lowest cruciferous intake (relative risk 0.87), and about 4.5% lower risk for every extra 15 g of cruciferous vegetables a day (relative risk 0.955). The European EPIC cohort and the Multiethnic Cohort have shown comparable inverse associations. Sulforaphane has been shown to inhibit androgen-receptor signaling in prostate cancer cell lines and to induce apoptosis in androgen-independent tumor models — the latter mechanism being clinically interesting given the current treatment-resistance problem in advanced prostate cancer.

A randomized, placebo-controlled trial (Cipolla 2015) gave 78 men whose prostate-specific antigen (PSA) was rising after prostate removal 60 mg a day of stabilized free sulforaphane (a purified compound, not broccoli-sprout extract) for 6 months. The trial did not reach its primary endpoint, a set slowing of the PSA slope. On secondary measures, PSA rose less with sulforaphane than with placebo (+0.099 vs +0.620 ng/mL over the 6 months), and PSA doubling time was 86% longer (28.9 vs 15.5 months) — a longer doubling time means PSA was rising more slowly. Two months after treatment stopped, the PSA slopes of the two groups were the same. Larger confirmatory trials are in progress.

Colorectal cancer. The cruciferous-and-colorectal-cancer association is somewhat weaker than for breast or prostate but consistent across cohorts. The 2013 meta-analysis by Wu et al. pooled 35 studies (24 case-control and 11 prospective) and found an 18% lower colorectal cancer risk comparing the highest with the lowest cruciferous intake (relative risk 0.82); the prospective studies on their own showed only borderline statistical significance. The effect is stronger for left-sided (distal) colon and rectal cancer than for right-sided (proximal) colon cancer.

Sulforaphane has direct effects on colorectal cancer cell lines (apoptosis induction, cell cycle arrest, Wnt-pathway inhibition) and indirect effects through the gut microbiome — cruciferous-rich diets alter gut bacterial composition toward populations with higher short-chain fatty acid (butyrate) production, which has independent colon-protective effects.

Back to Table of Contents

Lung and Bladder Cancer

Lung cancer. The cruciferous-and-lung-cancer association is strongest in current smokers, where dietary isothiocyanates accelerate detoxification of tobacco-smoke carcinogens (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or NNK, benzo[a]pyrene, polycyclic aromatic hydrocarbons). The China Health and Nutrition Study and the Singapore Chinese Health Study have shown 20-40% reductions in lung cancer risk among smokers in the highest cruciferous-intake quintiles. The effect among never-smokers is smaller but still present.

A 2025 randomized trial in 43 former smokers at high risk for lung cancer gave a daily dose of about 95 µmol sulforaphane or placebo for 12 months (37 finished). Sulforaphane did not change the bronchial tissue changes seen under the microscope, but the cell-growth marker Ki-67 in bronchial biopsies fell 20% with sulforaphane while it rose 65% with placebo; no severe side effects were seen. Ki-67 is a possible stand-in marker for lung cancer risk, not a cancer outcome.

Bladder cancer. The cruciferous-and-bladder-cancer association has been documented in the Health Professionals Follow-up Study, the Vitamins and Lifestyle (VITAL) study, and a Phase II clinical trial of broccoli-sprout extract in non-muscle-invasive bladder cancer. Mechanistically, isothiocyanates concentrate in the urine after dietary intake (urinary mercapturic acid metabolites are elevated for 24-48 hours after cruciferous consumption), providing direct exposure to bladder epithelial cells. The Bladder Cancer Advocacy Network has summarized the trial evidence. A 2022 meta-analysis of cohort studies, however, found no significant link between the highest cruciferous intake and lower bladder cancer risk (relative risk 0.92, 95% confidence interval 0.80-1.06), and its authors wrote that the results did not support the hypothesis.

Back to Table of Contents

GSTM1 / GSTT1 Polymorphisms and Personal Variability

Two common glutathione S-transferase polymorphisms strongly modify individual response to dietary isothiocyanates:

The direction of this effect is not settled. Some studies suggest that individuals with one or both null genotypes derive proportionally larger benefit from cruciferous-vegetable intake than individuals with intact GSTM1 / GSTT1, while a 2009 review by Lampe notes that pharmacokinetic studies link a missing GSTM1 enzyme to faster excretion of sulforaphane, so these people may derive less benefit. Either way, genotype explains some of the inter-individual variability in epidemiologic effect sizes.

Back to Table of Contents

Broccoli Sprouts vs Mature Kale: Concentration vs Practicality

Three-day-old broccoli sprouts contain 10-100 times the glucoraphanin concentration of mature broccoli on a per-gram basis. A single tablespoon of fresh broccoli sprouts (~10 g) can contain as much glucoraphanin as a full head of mature broccoli. This concentration advantage is why the Johns Hopkins research program focused on sprouts as the experimental delivery vehicle for sulforaphane.

However, sprouts present practical challenges that mature greens do not:

Mature kale is the pragmatic compromise: lower glucoraphanin concentration per gram, but much higher per-serving volume (one cup of kale >> one tablespoon of sprouts), excellent food safety, year-round availability, low cost, and broader culinary versatility. Kale, broccoli, brussels sprouts and cabbage all supply glucosinolates as everyday foods; sprouts add a more concentrated amount, with the food-safety risk described above.

Back to Table of Contents

Preparation for Maximum Bioactive Yield

Put together, these findings describe a simple kitchen pattern: kale chopped and left to sit 5-10 minutes on the cutting board, then steamed or sauteed briefly, with olive oil and a pinch of mustard seed for flavor. It does not give the absolute maximum bioactive yield, but it keeps far more than overboiled kale.

Back to Table of Contents

Cautions and Drug Interactions

Back to Table of Contents

Key Research Papers

  1. Talalay P, Fahey JW (2001). Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. Journal of Nutrition 131(11 Suppl):3027S-33S — PubMed PMID: 11694642
  2. Zhang Y, Talalay P, Cho CG, Posner GH (1992). A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. PNAS 89(6):2399-403 — PubMed PMID: 1549603
  3. Fahey JW, Zhang Y, Talalay P (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. PNAS — PubMed PMID: 9294217
  4. Kensler TW, Ng D, Carmella SG, Chen M, Jacobson LP, Munoz A, Egner PA, Chen JG, Qian GS, Chen TY, Fahey JW, Talalay P, Groopman JD, Yuan JM, Hecht SS (2012). Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis — PubMed PMID: 22045030 · Search PubMed
  5. Liu X, Lv K (2013). Cruciferous vegetables intake is inversely associated with risk of breast cancer: a meta-analysis. The Breast — PubMed PMID: 22877795 · Search PubMed
  6. Wu QJ, Yang Y, Vogtmann E, Wang J, Han LH, Li HL, Xiang YB (2013). Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies. Annals of Oncology — PubMed PMID: 23211939 · Search PubMed
  7. Cipolla BG, Mandron E, Lefort JM, Coadou Y, Della Negra E, Corbel L, Le Scodan R, Azzouzi AR, Mottet N (2015). Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy. Cancer Prevention Research — PubMed PMID: 25968598 · Search PubMed
  8. Higdon JV, Delage B, Williams DE, Dashwood RH (2007). Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological Research — PubMed PMID: 17317210
  9. Lampe JW, King IB, Li S, Grate MT, Barale KV, Chen C, Feng Z, Potter JD (2000). Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans. Carcinogenesis — PubMed PMID: 10837004 · Search PubMed
  10. Bradlow HL, Telang NT, Sepkovic DW, Osborne MP (1996). 2-hydroxyestrone: the 'good' estrogen. Journal of Endocrinology — PubMed PMID: 8943806 · Search PubMed
  11. Lampe JW (2009). Interindividual differences in response to plant-based diets: implications for cancer risk. American Journal of Clinical Nutrition 89(5):1553S-1557S — PubMed PMID: 19297461
  12. Atwell LL, Beaver LM, Shannon J, Williams DE, Dashwood RH, Ho E (2015). Epigenetic regulation by sulforaphane: opportunities for breast and prostate cancer chemoprevention. Current Pharmacology Reports — PubMed PMID: 26042194 · Search PubMed
  13. Cohen JH, Kristal AR, Stanford JL (2000). Fruit and vegetable intakes and prostate cancer risk. Journal of the National Cancer Institute 92(1):61-8 — PubMed PMID: 10620635
  14. Nechuta S, Caan BJ, Chen WY, Kwan ML, Lu W, Cai H, Poole EM, Flatt SW, Zheng W, Pierce JP, Shu XO (2013). Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiology, Biomarkers & Prevention 22(8):1451-6 — PubMed PMID: 23765086
  15. Long J, Liu Z, Liang S, Chen B (2023). Cruciferous Vegetable Intake and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Urologia Internationalis 107(7):723-733 — PubMed PMID: 37343525
  16. Yu P, Yu L, Lu Y (2022). Dietary consumption of cruciferous vegetables and bladder cancer risk: A systematic review and meta-analysis. Frontiers in Nutrition 9:944451 — PubMed PMID: 36061884
  17. Yuan JM, Kensler TW, Dacic S, Hartman DJ, Wang R, Balogh PA, Sufka P, Turner MA, Fuhrer K, Seigh L, Pham YT, Adams-Haduch J, Valacchi G, Singh SV, Herman JG, Wilson DO (2025). Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer. Cancer Prevention Research 18(6):335-345 — PubMed PMID: 40041932
  18. Guo C, Liu Y, Fu H, Zhang X, Li M (2024). Effect of cruciferous vegetable intake on cancer: An umbrella review of meta-analysis. Journal of Food Science 89(9):5230-5244 — PubMed PMID: 39138635

PubMed Topic Searches

  1. PubMed: Sulforaphane NRF2 chemoprevention
  2. PubMed: Cruciferous and breast cancer
  3. PubMed: I3C/DIM estrogen metabolism
  4. PubMed: GSTM1/GSTT1 polymorphisms
  5. PubMed: Broccoli sprouts

Back to Table of Contents

Connections

Back to Table of Contents